Tag - medicine-4

 
Menu
Search
 
July 28, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE 4

Japan Times
ASIA PACIFIC
Jun 11, 2021
Indians still battling impacts of COVID-19 now burdened with medical debt
Even before the pandemic struck, India's out-of-pocket expenses on health care were among the highest in the world.
Japan Times
COMMENTARY / World
Jun 10, 2021
Fixing the broken pandemic financing system
The devastation caused by COVID-19 has underscored what experts have said for years: our national, regional and global systems are grossly inadequate for detecting and containing outbreaks.
Japan Times
BUSINESS
Jun 9, 2021
Eisai sees potential of new Alzheimer's drug but costs remain concern
The approval by the U.S. Food and Drug Administration of the drug Aduhelm raised hopes, but patients can expect to be charged $56,000 a year.
Japan Times
WORLD
Jun 9, 2021
Biggest vaccine-maker’s problems keep world short of COVID-19 shots
The Serum Institute of India's travails have become a key illustration of how the effort to inoculate against COVID-19 has failed the developing world.
Japan Times
JAPAN / Science & Health
Jun 8, 2021
Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug
The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.
Japan Times
COMMENTARY / World
Jun 7, 2021
The world should learn from India’s COVID-19 cataclysm
Strategies that kept the pandemic at bay in 2020 won't necessarily work in 2021.
Japan Times
COMMENTARY / World
Jun 6, 2021
Lessons from the pandemic
Most countries are lagging far behind and new, concerted and more generous efforts by the richest nations are needed to control the pandemic at a global level.
Japan Times
JAPAN / FOCUS
Jun 4, 2021
In Japan, the light at the end of the pandemic's tunnel remains distant
The vaccine rollout may be accelerating, but the nation remains far away from a return to normalcy.
Japan Times
BUSINESS / FOCUS
Jun 4, 2021
Chinese drugmakers take aim at lucrative U.S. anti-cancer market
In recent years, medicines that free the immune system to attack tumors have become blockbusters in a $150 billion global market.
Japan Times
JAPAN / Science & Health
Jun 3, 2021
Japan to prioritize students heading abroad for COVID-19 vaccinations
The move comes as some schools in countries such as the United States have adopted requirements for students to be inoculated before they are allowed to participate in in-person classes.
Japan Times
JAPAN / Science & Health
Jun 3, 2021
Japan pledges $800 million for global COVID-19 vaccination effort
The COVAX Facility has beaten its goal of raising $8.3 billion to secure 1.8 billion doses, enough for 30% of the population of developing countries, Prime Minister Yoshihide Suga said.
Japan Times
JAPAN / Science & Health
May 30, 2021
COVID-19 vaccines to be available to all under 65 in Japan at same time
The central government is also considering administering U.S. pharmaceutical company Moderna Inc.'s vaccine, which was approved in Japan in May.
Japan Times
WORLD / Science & Health
May 28, 2021
AstraZeneca clot research continues amid German theory
German researchers said this week they discovered a link between the vaccine and rare blood clots.
Japan Times
WORLD / Science & Health
May 27, 2021
Immunity to the coronavirus may persist for years, scientists find
The findings may help put to rest lingering fears that protection against the virus will be short-lived.
Japan Times
COMMENTARY / World
May 26, 2021
Our responsibility to South Asia
Beyond inflicting agony on the sick, the coronavirus outbreak in the world's most populous democracy is now robbing victims of their dignity in death, too.
Japan Times
COMMENTARY / World
May 26, 2021
Sexy tea, the 'Lion King' and Taiwan's lost innocence
In just one week earlier this month, the case count for COVID-19 infections in Taiwan spiked by more than 40%, and it's likely that figure will keep climbing.
Japan Times
COMMENTARY / World
May 24, 2021
Asia’s COVID-19 surges should worry us all
Variants must be caught before they explode, and we can't afford to overlook what's happening now across the region.
Japan Times
JAPAN / Science & Health
May 23, 2021
Japan clinical trial of COVID-19 plasma therapy highlights slow-moving medical policy
Doctors are gearing up for clinical trials of convalescent plasma therapy, but many overseas hospitals have already moved on to other remedies.
Japan Times
WORLD
May 21, 2021
Delaying second doses offers wider immunity where vaccines are scarce
The initially controversial strategy has now been vindicated by scientific studies, allowing supplies to be more widely distributed and boosting their protective power.
Japan Times
WORLD / Science & Health
May 21, 2021
The latest coronavirus comes from dogs
Scientists have discovered a new canine coronavirus in a child who was hospitalized with pneumonia in Malaysia in 2018. If the virus is confirmed to be a human pathogen, it would be the eighth coronavirus, and the first canine coronavirus, known to cause disease in humans.
Japan's population continues to fall even as foreign resident count rises
The number of residents in Tokyo as of Jan. 1 rose by 0.03% from a year before, data shows, marking a year-on-year increase for the first time in three years, while the country's other 46 prefectures saw their populations continue to decline.
Ahead of the Olympics, Japan is still talking about the gymnast who won't be there
Japan's Shoko Miyata withdrew from the gymnastics team herself over her drinking and smoking, although it had already appeared as though the association was prepared to send her home from the team’s training camp in Monaco.
Yen melt-up nudges Japanese stocks into correction territory
Japanese stocks are down 10% from their July peak as the yen strengthens.
‘Crazy’ yen rally is at risk of shattering as soon as Wednesday
Some investors are warning that a yen rally is fragile, as was on show this week when the yen rapidly retraced an advance after Thursday’s stronger-than-expected U.S. economic growth figures.
Paris Olympics kick off with rain-soaked — but grandiose — opening ceremony
Japan's 2024 Olympic team moves down the Seine River in Paris during the opening ceremony of the 2024 Summer Olympics on Friday.
The Japanese Olympians looking to shine in Paris
Rim Nakamura, who is attempting to win Japan's first Olympic gold medal in cycling, will be one of the top Japanese athletes to watch at the Paris Games.
Japan’s minimum wage set for record ¥50 hike in major boost
Demonstrators rally to demand a big hike in minimum wages in Tokyo last week.
Japan loses top spot on strongest passport list to Singapore
Japan had the strongest passport for six years running from 2018, before being dethroned by Singapore on the 2024 list.
Why Japan's mysterious stash of classified funds escapes scrutiny
Prime Minister Fumio Kishida and Chief Cabinet Secretary Yoshimasa Hayashi (right) during a meeting in Tokyo on Tuesday.
Japan eyes gold — and the future — as Olympic men's soccer campaign begins
Japan midfielder Yu Hirakawa controls the ball during a match against the United States in Kansas City, Kansas, on June 11.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Traditional folk rituals like Mizudome-no-mai (dance to stop the rain) provide a sense of agency to a population that feels largely powerless in the face of the climate crisis.
As climate extremes intensify, Japan embraces ancient weather rituals
By Alex K.T. Martin

SUSTAINABLE JAPAN

mission sustainability vol.11 : Sekisui House Ltd.World’s top homebuilder acts on its responsibility
mission sustainability vol.11 : Sekisui House Ltd.World’s top homebuilder acts on its responsibility

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER